Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players’ financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

Anophthalmia and Microphthalmia Market Analysis

ID: MRFR//3302-HCR | 135 Pages | Author: Rahul Gotadki| May 2024

Anophthalmia and microphthalmia are interesting inborn circumstances described by immature or missing eyes. While these circumstances are somewhat uncommon, they influence a critical number of people internationally, with differing levels of significance.
The market for anophthalmia and microphthalmia is driven by the demand for powerful treatment choices to address visual weakness and related entanglements. Patients and parental figures look for intercessions that can work on visual capability, improve corrective appearance, and alleviate practical impediments related with these circumstances.
The treatment landscape for anophthalmia and microphthalmia incorporates a scope of intercessions pointed toward tending to visual deficiencies and tasteful worries. Careful intercessions like orbital implants, prosthetic eyes, and reconstructive procedures are generally utilized to work on visual appearance and reestablish facial consistency.
Organizations entering the market for anophthalmia and microphthalmia face different section boundaries, including administrative obstacles, repayment difficulties, and rivalry from established players. Exploring these interferences requires an exhaustive understanding of the administrative landscape, market elements, and patient necessities.
The market for anophthalmia and microphthalmia is portrayed by continuous innovative work efforts pointed toward propelling treatment choices and working on quiet results. Research drives center around imaginative careful methods, prosthetic materials, and regenerative treatments to address the intricate requirements of patients with these circumstances.
Looking forward, the market elements of anophthalmia and microphthalmia are supposed to develop with progresses in exploration, innovation, and medical services delivery. Efforts to further develop awareness, admittance to mind, and treatment results will keep on molding the market landscape, offering expect people impacted by these uncommon inherited eye conditions.

Anophthalmia and Microphthalmia Market Scenario


The anophthalmia and microphthalmia market is expected to reach USD 5,967.90 Million by 2030 at 4.70% CAGR during the forecast period 2022-2030.Anophthalmia and microphthalmia mean the absence of an eye and the presence of a small eye within the orbit. Anophthalmia and microphthalmia are interchangeable. Whereas, microphthalmia is a disorder in which one or both eyes are abnormally small, while anophthalmia is the absence of one or both eyes. Anophthalmia and microphthalmia mostly occur during pregnancy. However, anophthalmia and microphthalmia often result in blindness or limited vision. It is a rare disorder and the severe case has treatment unavailability.


The major causes may include genetic mutations and abnormal chromosomes. Exposure to X-rays, chemicals, drugs, pesticides, toxins, radiation, or viruses, increases the risk of anophthalmia and microphthalmia. Anophthalmia and microphthalmia lead to optic disc dysplasia as well as non-ocular features like mental retardation, neurological abnormalities, and facial dysmorphisms.


The anophthalmia and microphthalmia market growth is majorly attributed to the increasing prevalence of the genetic disorders and eye-related disorders. Moreover, the increasing mental retardation, neurological abnormalities are expected to drive the Anophthalmia and Microphthalmia Market growth over the assessment period.


According to the World Health Organization (WHO), an estimated 253 million people live with vision impairment 36 million are blind and 217 million have moderate to severe vision impairment worldwide. An estimated 19 million children (below age 15) are vision impaired.


Furthermore, According to the WHO estimates, neurological abnormalities are responsible for 4.5%-11% of all illnesses including low or high-income economies. This is far higher as compared to the number of respiratory ailments, gastrointestinal disorders, or cancers, and the burden is expected to increase further over the coming years.


However, availability of expensive treatment and poor reimbursement policies in the developing regions of the world are some of the factors, which may hamper the market growth during the forecast period.


Intended Audience



  • Pharmaceutical Companies

  • Research and Development (R&D) Companies

  • Government Research Institute

  • Academic Institutes and Universities

  • Medical Research Laboratories

  • Market Research and Consulting Service Providers

  • Potential Investors


Figure: Anophthalmia and Microphthalmia Market, By Region Market Share, 2016 (%) Anophthalmia and Microphthalmia Market

Sources: Annual reports, Press release, White paper, Company presentation


Segmentations


The anophthalmia and microphthalmia market is segmented on the basis by diagnosis, by treatment, and by the end user.


On the basis of the diagnosis, it is segmented into CT scan, MR scan, chromosome analysis, ultrasonography, and others.  


On the basis of treatment, it is segmented into surgery and others.


On the basis of the end user, it is segmented into hospitals & clinics, research centers, and others.


Regional Analysis


The Americas dominate the anophthalmia and microphthalmia market owing to well-developed technology, increased patient pool with genetic disorders, high health care spending, and government support for research & development. Furthermore, increased R&D activities and the concentration of major companies have fuelled the growth of the Anophthalmia and Microphthalmia Market in this region.


Europe holds the second position in the anophthalmia and microphthalmia market owing to the government support for research & development and availability of funds for research. This is expected to continue to drive the European market over the forecasted period.


Asia Pacific is the fastest growing anophthalmia and microphthalmia market owing to the presence of rapidly developing healthcare technology, huge patient population, and high healthcare expenditure. Moreover, increasing demand for new treatment methods in countries like India and South Korea is likely to emerge as the fastest growing market across the globe. Furthermore, increasing demand for quality devices in the healthcare is projected to lead the use of advanced equipment, which, in turn, may increase the growth of the anophthalmia and microphthalmia market in the region.


On the other hand, in the Middle East and Africa, blood disorders have become a huge problem due to limited screening, ignorance of diseases, and poor access to treatment. 


Key Players


Some of key the players in the Anophthalmia and Microphthalmia Market are Bristol-Myers Squibb Company, NUSAPURE, ALLERGAN, Aerie Pharmaceuticals, Inc., Pfizer Inc., Valeant Pharmaceuticals International, Inc., Bayer AG, Genentech, Inc., Novartis AG , Regeneron Pharmaceuticals, Inc., Shire, and Santen Pharmaceutical Co., Ltd., and others.


Research Methodology Anophthalmia and Microphthalmia Market-


Sources: Annual reports, Press release, White paper, and Company presentation

Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Kindly complete the form below to receive a free sample of this Report
Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.